We are live on ! Find out more
FOLD

Amicus Therapeutics
FOLD

Delisted

FOLD was delisted on the 24th of April, 2026.

Back to rankings

109 hedge funds and large institutions have $662M invested in Amicus Therapeutics in 2014 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 46 increasing their positions, 17 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

171% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 17

136% more capital invested

Capital invested by funds: $280M → $662M (+$382M)

100% more funds holding in top 10

Funds holding in top 10: 3 → 6 (+3)

84% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 19

15% more funds holding

Funds holding: 95 → 109 (+14)

6% more call options, than puts

Call options by funds: $6.98M | Put options by funds: $6.56M

Holders
109
Holders Change
+14
Holders Change %
+14.74%
% of All Funds
2.91%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.16%
New
35
Increased
46
Reduced
17
Closed
19
Calls
$6.98M
Puts
$6.56M
Net Calls
+$424K
Net Calls Change
-$1.24M

Top Buyers

Rank Fund Capital Flow
1
SAM
Sectoral Asset Management
Quebec, Canada
+$31.3M
2
Citadel Advisors
Citadel Advisors
Florida
+$15.9M
3
Millennium Management
Millennium Management
New York
+$14.5M
4
State Street
State Street
Massachusetts
+$14.4M
5
PA
Perceptive Advisors
New York
+$14.4M

Top Sellers

Rank Fund Capital Flow
1
VAM
Visium Asset Management
New York
-$4.07M
2
BIM
Bogle Investment Management
Massachusetts
-$3.65M
3
NI
Numeric Investors
Massachusetts
-$3.4M
4
DM
Deerfield Management
New York
-$2.86M
5
Morgan Stanley
Morgan Stanley
New York
-$2.07M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
26
Fidelity Investments
Massachusetts
$4.68M – – –
SFM
27
Sphera Funds Management
Israel
$4.58M +$3.77M +550,000 New
PAMU
28
Pictet Asset Management (UK)
United Kingdom
$4.45M +$3.67M +534,705 New
Connor, Clark & Lunn Investment Management (CC&L)
29
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$4.38M +$2.67M +389,309 +285%
Renaissance Technologies
30
Renaissance Technologies
New York
$4.23M +$2.6M +378,300 +290%
TCP
31
Tourbillon Capital Partners
New York
$4.16M +$3.43M +500,000 New
TC
32
TFS Capital
Pennsylvania
$4.09M +$487K +71,002 +17%
BBA
33
Baker Bros. Advisors
New York
$4.01M – – –
Two Sigma Investments
34
Two Sigma Investments
New York
$3.56M -$388K -56,563 -12%
JGC
35
J. Goldman & Co
New York
$3.33M +$2.75M +400,000 New
Geode Capital Management
36
Geode Capital Management
Massachusetts
$3.31M +$1.04M +151,867 +62%
Morgan Stanley
37
Morgan Stanley
New York
$3.1M -$2.07M -301,372 -45%
Deutsche Bank
38
Deutsche Bank
Germany
$3.1M +$1.28M +186,513 +100%
GTC
39
Ghost Tree Capital
New York
$2.5M +$2.06M +300,000 New
ARTA
40
A.R.T. Advisors
New York
$2.47M +$2.04M +296,924 New
RFC
41
Russell Frank Company
Washington
$2.39M +$241K +35,137 +14%
OAM
42
Oxford Asset Management
United Kingdom
$2.28M +$1.81M +263,616 +1,987%
Bank of New York Mellon
43
Bank of New York Mellon
New York
$2.22M +$580K +84,544 +46%
SGAM
44
Smith Group Asset Management
Texas
$2.1M -$785K -114,310 -31%
Ameriprise
45
Ameriprise
Minnesota
$1.96M +$63.4K +9,236 +4%
Group One Trading
46
Group One Trading
Illinois
$1.96M +$457K +66,621 +39%
CAM
47
ClariVest Asset Management
California
$1.87M -$5.48K -798 -0.4%
MCM
48
Moore Capital Management
New York
$1.87M +$1.54M +225,000 New
BA
49
BlackRock Advisors
Delaware
$1.86M +$6.66K +971 +0.4%
California Public Employees Retirement System
50
California Public Employees Retirement System
California
$1.85M +$760K +110,800 +95%
1
2
3 4 5

FOLD Hedge Fund Activity: Q4 2014 in Review

109 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Amicus Therapeutics (FOLD) for Q4 2014, worth a combined $662M — up 136% from $280M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new FOLD positions and 19 closed out — a net gain of 16 holders — while 46 added to existing stakes and 17 trimmed.

The largest buyer was Sectoral Asset Management, adding an estimated $31.3M. The largest seller was Visium Asset Management, cutting an estimated $4.07M.

  • 109 institutional investors held Amicus Therapeutics (FOLD) as of Q4 2014, up from 95 in Q3 2014.
  • Funds reported $662M of Amicus Therapeutics stock for Q4 2014, up 136% quarter-over-quarter.
  • 35 funds opened new Amicus Therapeutics positions in Q4 2014 and 19 closed out, a net change of +16 holders.
  • The largest Amicus Therapeutics buyer in Q4 2014 was Sectoral Asset Management, an estimated $31.3M added.
  • The largest Amicus Therapeutics seller in Q4 2014 was Visium Asset Management, an estimated $4.07M sold.

Based on aggregated 13F filings for Q4 2014.